Neumentum and NEMA Research Inc. Named to Short-List of Citeline Awards for 2021
September 20, 2021 08:00 ET
|
Neumentum, Inc.
Nominated for Most Successful Early-Phase Research MORRISTOWN, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) -- The Citeline Awards, sponsored by Informa Pharma Intelligence, today announced that Neumentum...
Neumentum to Participate in the UBS Biotechnology Private Company Symposium
September 15, 2021 08:00 ET
|
Neumentum, Inc.
MORRISTOWN, N.J., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott...
Neumentum Presents Latest Data on NTM-006, a Novel Non-Opioid, Non-NSAID Analgesic Drug Candidate, at PAINWeek 2021
September 08, 2021 08:00 ET
|
Neumentum, Inc.
MORRISTOWN, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced data on NTM-006,...
Neumentum to Participate in Upcoming January Virtual Investor Conferences
January 05, 2021 07:00 ET
|
Neumentum, Inc.
MORRISTOWN, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively,...
Neumentum to Present New Data for Drug Candidate NTM-001 at the 2020 ASHP Midyear Clinical Meeting and Exhibition
December 08, 2020 08:00 ET
|
Neumentum, Inc.
MORRISTOWN, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – will present three posters at the...
Neumentum to Participate in the Jefferies Virtual London Healthcare Conference
November 05, 2020 08:00 ET
|
Neumentum, Inc.
MORRISTOWN, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively,...
Neumentum and Nuance Biotech Enter into Licensing Agreement for NTM-001 (ketorolac for IV infusion) in China
October 21, 2020 08:00 ET
|
Neumentum, Inc.
MORRISTOWN, N.J., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that the company...
Neumentum to Participate in the 18th Annual Morgan Stanley Virtual Global Healthcare Conference
September 10, 2020 08:00 ET
|
Neumentum, Inc.
MORRISTOWN, N.J., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott...
Neumentum Announces Two Poster Presentations for Novel Non-opioid, Non-NSAID Analgesic Drug Candidate at PAINWeek 2020
September 03, 2020 08:00 ET
|
Neumentum, Inc.
MORRISTOWN, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – will present two posters with data...
Neumentum Provides Corporate Update on Company’s Pipeline of Non-opioid Analgesic Programs
July 23, 2020 08:00 ET
|
Neumentum, Inc.
October 2020 Type C meeting planned with the FDA for NTM-006, an oral new chemical entity with a novel mechanism of action targeting neuropathic pain Based on recent FDA guidance letter,...